Mythili Koneru
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mythili Koneru
Marker Therapeutics, Inc. reported in an 8-K filed March 16, 2023 that Mythili Koneru resigned as Chief Medical Officer, effective April 9, 2023. The proxy statement of Marker Therapeutics, Inc. reports total compensation of $220,146 for Mythili Koneru in fiscal 2023, including a base salary of $135,346. Disclosed compensation is on record for 5 fiscal years.
“On March 13, 2023, Mythili Koneru, Chief Medical Officer of Marker Therapeutics, Inc. (the "Company"), notified the Company of her intent to resign as Chief Medical Officer of the Company effective as of April 9, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Marker Therapeutics, Inc. (MRKR)
Proxy statement
Start not stated–2023-04-09
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Marker Therapeutics, Inc. (MRKR) | our Former Chief Medical Officer | $135,346 | $220,146 |
| 2022 | Marker Therapeutics, Inc. (MRKR) | Former Chief Medical Officer | $424,269 | $632,382 |
| 2021 | Marker Therapeutics, Inc. (MRKR) | Former Chief Medical Officer | $405,827 | $901,538 |
| 2020 | Marker Therapeutics, Inc. (MRKR) | Chief Medical Officer | $398,600 | $782,200 |
| 2019 | Marker Therapeutics, Inc. (MRKR) | Chief Medical Officer | $313,542 | $1,843,763 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.